ITMI20031640A1 - Base per gel bioadesivi. - Google Patents

Base per gel bioadesivi.

Info

Publication number
ITMI20031640A1
ITMI20031640A1 IT001640A ITMI20031640A ITMI20031640A1 IT MI20031640 A1 ITMI20031640 A1 IT MI20031640A1 IT 001640 A IT001640 A IT 001640A IT MI20031640 A ITMI20031640 A IT MI20031640A IT MI20031640 A1 ITMI20031640 A1 IT MI20031640A1
Authority
IT
Italy
Prior art keywords
base
bioadhesive gel
bioadhesive
gel
hydroxyethylcellulose
Prior art date
Application number
IT001640A
Other languages
English (en)
Inventor
Massimo Prini
Original Assignee
Mipharm S P A
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Mipharm S P A filed Critical Mipharm S P A
Priority to IT001640A priority Critical patent/ITMI20031640A1/it
Priority to US10/567,890 priority patent/US20070031479A1/en
Priority to PT04763658T priority patent/PT1651274E/pt
Priority to CA2535123A priority patent/CA2535123C/en
Priority to AT04763658T priority patent/ATE395084T1/de
Priority to PCT/EP2004/008577 priority patent/WO2005014047A1/en
Priority to ES04763658T priority patent/ES2305818T3/es
Priority to SI200430777T priority patent/SI1651274T1/sl
Priority to CN200480022719XA priority patent/CN1832760B/zh
Priority to DE602004013787T priority patent/DE602004013787D1/de
Priority to DK04763658T priority patent/DK1651274T3/da
Priority to BRPI0413446-0A priority patent/BRPI0413446A/pt
Priority to PL04763658T priority patent/PL1651274T3/pl
Priority to EP04763658A priority patent/EP1651274B1/en
Priority to JP2006522300A priority patent/JP4855935B2/ja
Publication of ITMI20031640A1 publication Critical patent/ITMI20031640A1/it
Priority to CY20081100793T priority patent/CY1108548T1/el
Priority to US13/293,484 priority patent/US8790685B2/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0034—Urogenital system, e.g. vagina, uterus, cervix, penis, scrotum, urethra, bladder; Personal lubricants
    • A61K9/0036—Devices retained in the vagina or cervix for a prolonged period, e.g. intravaginal rings, medicated tampons, medicated diaphragms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A61K47/38—Cellulose; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P23/00—Anaesthetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10—Antimycotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
IT001640A 2003-08-08 2003-08-08 Base per gel bioadesivi. ITMI20031640A1 (it)

Priority Applications (17)

Application Number Priority Date Filing Date Title
IT001640A ITMI20031640A1 (it) 2003-08-08 2003-08-08 Base per gel bioadesivi.
SI200430777T SI1651274T1 (sl) 2003-08-08 2004-07-30 Bioadheziven gel na osnovi hidroksietilceluloze
DK04763658T DK1651274T3 (da) 2003-08-08 2004-07-30 Bioadhæsivt gel på basis af hydroxyethylcellulose
CA2535123A CA2535123C (en) 2003-08-08 2004-07-30 Bioadhesive gel based on hydroxyethylcellulose
AT04763658T ATE395084T1 (de) 2003-08-08 2004-07-30 Bioadhäsives gel auf basis von hydroxyethylcellulose
PCT/EP2004/008577 WO2005014047A1 (en) 2003-08-08 2004-07-30 Bioadhesive gel based on hydroxyethylcellulose
ES04763658T ES2305818T3 (es) 2003-08-08 2004-07-30 Gel bioadhesivo a base de hidroxietilcelulosa.
US10/567,890 US20070031479A1 (en) 2003-08-08 2004-07-30 Bioadhesive gel based on hydroxyethycellulose
CN200480022719XA CN1832760B (zh) 2003-08-08 2004-07-30 基于羟乙基纤维素的生物粘附性凝胶
DE602004013787T DE602004013787D1 (de) 2003-08-08 2004-07-30 Bioadhäsives gel auf basis von hydroxyethylcellulose
PT04763658T PT1651274E (pt) 2003-08-08 2004-07-30 Gel bio-adesivo à base de hidroxietilcelulose
BRPI0413446-0A BRPI0413446A (pt) 2003-08-08 2004-07-30 gel bioadesivo á base de hidroxietilcelulose
PL04763658T PL1651274T3 (pl) 2003-08-08 2004-07-30 Żel bioadhezyjny na bazie hydroksyetylocelulozy
EP04763658A EP1651274B1 (en) 2003-08-08 2004-07-30 Bioadhesive gel based on hydroxyethylcellulose
JP2006522300A JP4855935B2 (ja) 2003-08-08 2004-07-30 ヒドロキシエチルセルロースに基づく生体接着性ゲル
CY20081100793T CY1108548T1 (el) 2003-08-08 2008-07-30 Βιοπροσκολλητικη γελη βασισμενη σε υδροξυαιθυλοκυτταρινη
US13/293,484 US8790685B2 (en) 2003-08-08 2011-11-10 Bioadhesive gel based on hydroxyethylcellulose

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT001640A ITMI20031640A1 (it) 2003-08-08 2003-08-08 Base per gel bioadesivi.

Publications (1)

Publication Number Publication Date
ITMI20031640A1 true ITMI20031640A1 (it) 2005-02-09

Family

ID=34131212

Family Applications (1)

Application Number Title Priority Date Filing Date
IT001640A ITMI20031640A1 (it) 2003-08-08 2003-08-08 Base per gel bioadesivi.

Country Status (16)

Country Link
US (2) US20070031479A1 (it)
EP (1) EP1651274B1 (it)
JP (1) JP4855935B2 (it)
CN (1) CN1832760B (it)
AT (1) ATE395084T1 (it)
BR (1) BRPI0413446A (it)
CA (1) CA2535123C (it)
CY (1) CY1108548T1 (it)
DE (1) DE602004013787D1 (it)
DK (1) DK1651274T3 (it)
ES (1) ES2305818T3 (it)
IT (1) ITMI20031640A1 (it)
PL (1) PL1651274T3 (it)
PT (1) PT1651274E (it)
SI (1) SI1651274T1 (it)
WO (1) WO2005014047A1 (it)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN100394919C (zh) * 2006-03-01 2008-06-18 杨军 一种用于治疗阴道疾病的药物组合物
US8433851B2 (en) 2007-08-16 2013-04-30 International Business Machines Corporation Reducing wiring congestion in a cache subsystem utilizing sectored caches with discontiguous addressing
US9446131B2 (en) 2013-01-31 2016-09-20 Merz Pharmaceuticals, Llc Topical compositions and methods for making and using same
US9433680B2 (en) 2013-01-31 2016-09-06 Merz Pharmaceuticals, Llc Topical compositions and methods for making and using same
US8778365B1 (en) 2013-01-31 2014-07-15 Merz Pharmaceuticals, Llc Topical compositions and methods for making and using same
US9452173B2 (en) 2013-01-31 2016-09-27 Merz Pharmaceuticals, Llc Topical compositions and methods for making and using same
CN106310266A (zh) * 2015-07-09 2017-01-11 王强 一种预防或治疗粘膜疾病的组合物及制备方法
CN106109398A (zh) * 2016-06-14 2016-11-16 上海通用药业股份有限公司 一种含有噻康唑的阴道用凝胶
CN106038477A (zh) * 2016-06-14 2016-10-26 上海通用药业股份有限公司 一种含有噻康唑的阴道用凝胶的制备方法
RS62022B1 (sr) * 2016-07-08 2021-07-30 Acraf Farmaceutska kompozicija koja sadrži benzidamin
IT201900000388A1 (it) * 2019-01-10 2020-07-10 L N Age S R L Composizione per l'uso nel trattamento di lesioni vaginali, del glande ed anali
EP3986378A1 (en) * 2019-06-21 2022-04-27 Alfasigma S.p.A. Pharmaceutical compositions in the form of gel containing xyloglucan and alcohols for the controlled release of active ingredients
CN111557897B (zh) * 2020-07-07 2023-06-23 温州海鹤药业有限公司 一种含有硝呋太尔的药物组合物及其制备方法

Family Cites Families (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3731255A1 (de) * 1987-09-17 1989-04-06 Boehringer Ingelheim Int Stabilisierung von therapeutisch wirksamen proteinen in pharmazeutischen zubereitungen
DE3741149A1 (de) * 1987-12-04 1989-06-15 Thomae Gmbh Dr K Zubereitungsformen zur verhinderung von adhaesionen von organen und organteilen
JPH04217925A (ja) * 1990-03-27 1992-08-07 Nippon Saafuakutanto Kogyo Kk 新規な解熱消炎鎮痛剤組成物
JPH05178763A (ja) * 1991-02-19 1993-07-20 Nippon Saafuakutanto Kogyo Kk 難溶解性薬物溶解剤組成物
US5667492A (en) 1994-10-07 1997-09-16 Columbia Laboratories, Inc. Use and composition of an anti-sexually transmitted diseases formulation
AT408067B (de) * 1995-03-17 2001-08-27 Gebro Pharma Gmbh Pharmazeutische zusammensetzung zur topischen applizierung und verfahren zu ihrer herstellung
US5849761A (en) * 1995-09-12 1998-12-15 Regents Of The University Of California Peripherally active anti-hyperalgesic opiates
JP3616688B2 (ja) * 1996-03-25 2005-02-02 太田製薬株式会社 医薬組成物
BR9709792A (pt) * 1996-06-12 1999-08-10 Procter & Gamble Utilização de antagonistas h2 para a fabricação de uma composição tópica para o tratamento de resfriados
IT1284874B1 (it) 1996-08-02 1998-05-22 Farmigea Spa Complessi bioadesivi di polycarbophil e farmaci antifungini o antiprotozoari azolici
US5871715A (en) * 1997-02-28 1999-02-16 Gillette Canada Inc. Stannous fluoride gel with improved stand-up
CA2289966A1 (en) * 1997-05-14 1998-11-19 Galen (Chemicals) Limited Topical compositions
US6416779B1 (en) * 1997-06-11 2002-07-09 Umd, Inc. Device and method for intravaginal or transvaginal treatment of fungal, bacterial, viral or parasitic infections
WO2000015192A1 (en) 1998-09-17 2000-03-23 Zonagen, Inc. Methods and materials related to bioadhesive contraceptive gels
US6159491A (en) 1999-02-12 2000-12-12 Biovector Technologies, Inc. Prolonged release bioadhesive vaginal gel dosage form
ATE350011T1 (de) * 1999-10-22 2007-01-15 Lif Hlaup Ehf Bio Gels Pharmac Pharmazeutische zusammensetzung zur behandlung von ulzerationen und/oder erosionen des schleimhautepithels
FR2802097B1 (fr) 1999-12-14 2002-12-13 Invest S Therapeutiques Essais Composition sous forme de gel prevue pour recevoir un principe actif en solution ou en suspension, notamment pour application sur une muqueuse et procede de fabrication
ATE356636T1 (de) * 2000-08-03 2007-04-15 Antares Pharma Ipl Ag Zusammensetzung zur transdermalen und/oder transmukosalen verabreichung von wirkstoffen, die ausreichende therapeutische spiegel garantiert
IL142037A0 (en) * 2001-03-15 2002-03-10 Agis Ind 1983 Ltd Pharmaceutical compositions containing a non-steroidal anti-inflammatory drug
AU2002329842B2 (en) * 2001-08-29 2006-09-14 Umd, Inc. Vaginal delivery of chemotherapeutic agents and inhibitors of membrane efflux systems for cancer therapy
EP1480517A4 (en) * 2002-02-07 2007-08-22 Univ Columbia ZINC SALT COMPOSITIONS FOR PREVENTING MOLECULAR BREAST EXTRACTION THROUGH SPERMICIDES AND MICROBICIDES
AR039540A1 (es) * 2002-05-13 2005-02-23 Tibotec Pharm Ltd Compuestos microbicidas con contenido de pirimidina o triazina

Also Published As

Publication number Publication date
US20070031479A1 (en) 2007-02-08
WO2005014047A1 (en) 2005-02-17
CN1832760A (zh) 2006-09-13
CA2535123A1 (en) 2005-02-17
CY1108548T1 (el) 2014-04-09
US8790685B2 (en) 2014-07-29
EP1651274B1 (en) 2008-05-14
DK1651274T3 (da) 2008-09-08
EP1651274A1 (en) 2006-05-03
PL1651274T3 (pl) 2008-10-31
DE602004013787D1 (de) 2008-06-26
PT1651274E (pt) 2008-08-11
ES2305818T3 (es) 2008-11-01
CN1832760B (zh) 2010-06-23
JP4855935B2 (ja) 2012-01-18
ATE395084T1 (de) 2008-05-15
SI1651274T1 (sl) 2008-10-31
JP2007533604A (ja) 2007-11-22
US20120083515A1 (en) 2012-04-05
CA2535123C (en) 2012-06-26
BRPI0413446A (pt) 2006-10-17

Similar Documents

Publication Publication Date Title
CY1108548T1 (el) Βιοπροσκολλητικη γελη βασισμενη σε υδροξυαιθυλοκυτταρινη
AR048878A1 (es) Composiciones topicas de metadona y metodos para usarlas
RS51764B (en) TRANSDERMAL PHARMACEUTICAL COMPOSITION
ATE445389T1 (de) Liposomale glucocorticoide
RS52504B (en) TRANSMUCOSE VETERINARY MIXTURE CONTAINING DETOMIDINE
DK1409034T3 (da) Topisk farmaceutisk formulering
DE60111933D1 (de) Gel zusammensetzungen
WO2007060512A3 (en) Compositions containing topical active agents and pentylene glycol
ATE269113T1 (de) Sprühfähige wundversorgungszusammensetzung
CY1108992T1 (el) Η χρηση του υαλουρονικου οξεος για την παρασκευη συνθεσεων για τη θεραπευτικη αντιμετωπιση υποτροπιαζουσων αφθων της στοματικης κοιλοτητας
WO2003066597A3 (en) Guanidino compounds
BRPI0208411B8 (pt) composto, composição farmacêutica tópica para tratamento profilático ou terapêutico de doenças sexualmente transmitidas em um paciente humano, e, uso de um composto
ATE454136T1 (de) Therapeutische zusammensetzungen zur pulmonalen verabreichung
ATE528009T1 (de) Reepithelialisierende pharmazeutische zusammensetzungen, die xanthangummi enthalten
PL402550A1 (pl) Dopochwowe kompozycje farmaceutyczne oraz zastosowanie zródla nadtlenku i bioadhezyjnego nosnika
EA200702496A1 (ru) Местная композиция, содержащая желатин
DE602006020666D1 (de) Methoden und Zusammensetzungen zur Beruhigung von Mund- und Nasenschleimhäuten
SE0001916D0 (sv) Novel formulation
EA200500671A1 (ru) Фармацевтический состав оланзапина
MXPA05008403A (es) Uso de acido comestible en formas de dosis solidas farmaceuticas de rapida dispersion.
EA200500175A1 (ru) Соль морфин-6-глюкуронида
PE20050359A1 (es) Composiciones topicas que comprenden terbinafina e hidrocortisona
WO2006026172A3 (en) Use of soluble cd26 as inhibitor of angiogenesis and inflammation
PL1799201T3 (pl) Żelowe kompozycje 4-hydroksytemoksyfenu
MXPA06002852A (es) Agentes antibacterianos de quinolona.